Eagle Bay Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54
| Closed | -$21.7K | – | 928 |
|
|
2024
Q4 | $21.7K | Hold |
54
| – | – | 0.01% | 449 |
|
|
2024
Q3 | $25.1K | Hold |
54
| – | – | 0.01% | 583 |
|
|
2024
Q2 | $25.3K | Hold |
54
| – | – | 0.02% | 414 |
|
|
2024
Q1 | $22.6K | Buy |
54
+23
| +74% | +$9.61K | 0.01% | 409 |
|
|
2023
Q4 | $12.6K | Hold |
31
| – | – | 0.01% | 482 |
|
|
2023
Q3 | $10.8K | Hold |
31
| – | – | 0.01% | 589 |
|
|
2023
Q2 | $10.9K | Hold |
31
| – | – | 0.01% | 591 |
|
|
2023
Q1 | $9.77K | Hold |
31
| – | – | 0.01% | 593 |
|
|
2022
Q4 | $8.95K | Hold |
31
| – | – | 0.01% | 607 |
|
|
2022
Q3 | $9K | Hold |
31
| – | – | 0.01% | 610 |
|
|
2022
Q2 | $8.74K | Buy |
+31
| New | +$8.74K | 0.01% | 649 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$1K | – | 949 |
|
|
2021
Q4 | $1K | Sell |
1
-51
| -98% | -$51K | ﹤0.01% | 1027 |
|
|
2021
Q3 | $9K | Hold |
52
| – | – | 0.01% | 725 |
|
|
2021
Q2 | $12K | Buy |
+52
| New | +$12K | 0.01% | 655 |
|